- All > Medicine Access and Rational Use > Antimicrobial Drug Resistance
- All > Public Health, Innovation, Intellectual Property and Trade > Research and Development (R&D) - Innovation and Financing
(2014; 38 pages)
WHO convened an ad hoc consultation on rapid methods for antimicrobial susceptibility testing at point-of-care in LMICs in Geneva from 8 to 9 April 2014. The objective was to facilitate dialogue between stakeholders including subject matter experts, representatives from industry, academia, NGOs, WHO and others, with the goal of creating a roadmap to stimulate development of and access to suitable rapid diagnostic tools for antimicrobial susceptibility testing (AST) at all levels of healthcare in LMICs, with an emphasis on point of care, where need is greatest. Discussion also covered the need for diagnostics for bacterial versus viral differentiation, and for pathogen identification.